{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:21:42Z","timestamp":1783102902735,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,28]],"date-time":"2027-05-28T00:00:00Z","timestamp":1811462400000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008663","name":"Health and Environmental Sciences Institute","doi-asserted-by":"publisher","award":["R01ES028668"],"award-info":[{"award-number":["R01ES028668"]}],"id":[{"id":"10.13039\/100008663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES006694"],"award-info":[{"award-number":["R01ES006694"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32ES007091"],"award-info":[{"award-number":["T32ES007091"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES028668"],"award-info":[{"award-number":["R01ES028668"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dmd.2026.100313","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:34:28Z","timestamp":1777617268000},"page":"100313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Altered renal disposition of adefovir in metabolic dysfunction\u2013associated steatohepatitis using the fast-food diet and thioacetamide-induced model to extrapolate renal secretion"],"prefix":"10.1016","volume":"54","author":[{"given":"Dominique O.","family":"Farrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton A.","family":"Sample","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina M.","family":"Alaaldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Martinez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0967-0866","authenticated-orcid":false,"given":"Jailyn M.","family":"Izu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"LaMadrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6410-2319","authenticated-orcid":false,"given":"Paige","family":"Lenzen-Hammerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6198-8718","authenticated-orcid":false,"given":"Mason","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-0017","authenticated-orcid":false,"given":"Stephen H.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dmd.2026.100313_bib1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen\u2013positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"issue":"50","key":"10.1016\/j.dmd.2026.100313_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005578","article-title":"Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: a meta-analysis","volume":"95","author":"Luo","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dmd.2026.100313_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2019.03.042","article-title":"Adefovir accumulation and nephrotoxicity in renal interstitium: role of organic anion transporters of kidney","volume":"224","author":"Zhou","year":"2019","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100313_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/pharmrev.123.001087","article-title":"Steatotic liver disease: pathophysiology and emerging pharmacotherapies","volume":"76","author":"Kokkorakis","year":"2024","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100313_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.30857","article-title":"Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B","volume":"71","author":"Choi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dmd.2026.100313_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100313_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/dmd.114.060574","article-title":"Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis","volume":"43","author":"Canet","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmd.2026.100313_bib8","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.apsb.2021.05.030","article-title":"Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity","volume":"11","author":"Jilek","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"10.1016\/j.dmd.2026.100313_bib9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/dmd.121.000451","article-title":"Attenuated ochratoxin A transporter expression in a mouse model of nonalcoholic steatohepatitis protects against proximal convoluted tubule toxicity","volume":"50","author":"Jilek","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"14","key":"10.1016\/j.dmd.2026.100313_bib10","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/CM9.0000000000002310","article-title":"Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease","volume":"135","author":"Tong","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.dmd.2026.100313_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1525-139X.2003.03011.x","article-title":"The effect of chronic renal failure on hepatic drug metabolism and drug disposition","volume":"16","author":"Dreisbach","year":"2003","journal-title":"Semin Dial"},{"issue":"4","key":"10.1016\/j.dmd.2026.100313_bib12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmd.2026.100313_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bcp.2016.07.001","article-title":"Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir","volume":"115","author":"Laho","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100313_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/dmd.122.001038","article-title":"Renal transporter alterations in patients with chronic liver diseases: nonalcoholic steatohepatitis, alcohol-associated, viral hepatitis, and alcohol-viral combination","volume":"51","author":"Frost","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2026.100313_bib15","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1124\/dmd.122.001133","article-title":"Representative rodent models for renal transporter alterations in human nonalcoholic steatohepatitis","volume":"51","author":"Frost","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100313_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2019.01.001","article-title":"Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL\/6J mice: a novel eight weeks model of fibrosing NASH","volume":"304","author":"Sharma","year":"2019","journal-title":"Toxicol Lett"},{"issue":"9","key":"10.1016\/j.dmd.2026.100313_bib17","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13205","article-title":"Validation of a routine two-sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD","volume":"5","author":"Turner","year":"2017","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.dmd.2026.100313_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/toxsci\/kfac070","article-title":"Increased renal expression of complement components in patients with liver diseases: nonalcoholic steatohepatitis, alcohol-associated, viral hepatitis, and alcohol-viral combination","volume":"189","author":"Frost","year":"2022","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100313_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/dmd.111.041095","article-title":"Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis","volume":"40","author":"Hardwick","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.dmd.2026.100313_bib20","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","author":"Lickteig","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2026.100313_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299507","article-title":"Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis","volume":"19","author":"Gurun","year":"2024","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.dmd.2026.100313_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/138920012803341302","article-title":"Drug disposition in pathophysiological conditions","volume":"13","author":"Gandhi","year":"2012","journal-title":"Curr Drug Metab"},{"issue":"12","key":"10.1016\/j.dmd.2026.100313_bib23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100313_bib24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmd.2026.100313_bib25","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.dmd.2026.100313_bib26","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease","volume":"39","author":"Lake","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2026.100313_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/dmd.114.062703","article-title":"Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis","volume":"43","author":"Canet","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2026.100313_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.116.234310","article-title":"Biliary elimination of pemetrexed is dependent on MRP2 in rats: potential mechanism of variable response in nonalcoholic steatohepatitis","volume":"358","author":"Dzierlenga","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.dmd.2026.100313_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfu156","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","volume":"142","author":"Hardwick","year":"2014","journal-title":"Toxicol Sci"},{"issue":"12","key":"10.1016\/j.dmd.2026.100313_bib30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/dmd.117.077644","article-title":"Pediatric cytochrome P450 activity alterations in nonalcoholic steatohepatitis","volume":"45","author":"Li","year":"2017","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2026.100313_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.dmd.2026.100313_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","article-title":"Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: two sides of the same coin","volume":"9","author":"Suriano","year":"2021","journal-title":"Microbiome"},{"issue":"4","key":"10.1016\/j.dmd.2026.100313_bib33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/dmd.113.055996","article-title":"Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models","volume":"42","author":"Canet","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"24","key":"10.1016\/j.dmd.2026.100313_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415791","article-title":"Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) research","volume":"23","author":"Flessa","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100313_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.114.220764","article-title":"Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis","volume":"352","author":"Dzierlenga","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.dmd.2026.100313_bib36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1124\/dmd.116.070722","article-title":"Lansoprazole exacerbates pemetrexed-mediated hematologic toxicity by competitive inhibition of renal basolateral human organic anion transporter 3","volume":"44","author":"Ikemura","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100313_bib37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/jpet.123.001979","article-title":"Characterization of human organic anion transporter 4 (hOAT4) and mouse Oat5 (mOat5) as functional orthologs for renal anion uptake and efflux transport","volume":"391","author":"Martinez-Guerrero","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.dmd.2026.100313_bib38","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","article-title":"Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity","volume":"2","author":"Hagos","year":"2010","journal-title":"Toxins (Basel)"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:52:33Z","timestamp":1783101153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0090955626000826"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100313","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered renal disposition of adefovir in metabolic dysfunction\u2013associated steatohepatitis using the fast-food diet and thioacetamide-induced model to extrapolate renal secretion","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100313"}}